Effects of PI3K inhibitor NVP-BKM120 on acquired resistance to gefitinib of human lung adenocarcinoma H1975 cells.

about

Expression and clinical significance of Semaphorin4D in non-small cell lung cancer and its impact on malignant behaviors of A549 lung cancer cells.

P2860

Q38964772-531215B3-0609-46F1-A2EE-ACA81EEEC0BB

P2860

Effects of PI3K inhibitor NVP-BKM120 on acquired resistance to gefitinib of human lung adenocarcinoma H1975 cells.

Item

http://www.wikidata.org/entity/Q39043339

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Effects of PI3K inhibitor NVP- ...... ng adenocarcinoma H1975 cells.

@en

Effects of PI3K inhibitor NVP- ...... ng adenocarcinoma H1975 cells.

@nl

type

Item

label

Effects of PI3K inhibitor NVP- ...... ng adenocarcinoma H1975 cells.

@en

Effects of PI3K inhibitor NVP- ...... ng adenocarcinoma H1975 cells.

@nl

prefLabel

Effects of PI3K inhibitor NVP- ...... ng adenocarcinoma H1975 cells.

@en

Effects of PI3K inhibitor NVP- ...... ng adenocarcinoma H1975 cells.

@nl

P1476

Effects of PI3K inhibitor NVP- ...... ng adenocarcinoma H1975 cells.

@en

P2093

Gang Wu

http://www.w3.org/2001/XMLSchema#string

Hong-ge Wu

http://www.w3.org/2001/XMLSchema#string

Hong-jian Xue

http://www.w3.org/2001/XMLSchema#string

Liang-liang Shi

http://www.w3.org/2001/XMLSchema#string

Qing Liu

http://www.w3.org/2001/XMLSchema#string

Tao Liu

http://www.w3.org/2001/XMLSchema#string

Yi-chen Liang

http://www.w3.org/2001/XMLSchema#string

P2860

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Cancer statistics, 2010

Analyzing real-time PCR data by the comparative C(T) method

The protein kinase B/Akt signalling pathway in human malignancy

The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

P2888

s11596-013-1209-5

P304

845-851

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11596-013-1209-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24337846

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma

Effects of PI3K inhibitor NVP-BKM120 on acquired resistance to gefitinib of human lung adenocarcinoma H1975 cells.

about

P2860

P2860

Effects of PI3K inhibitor NVP-BKM120 on acquired resistance to gefitinib of human lung adenocarcinoma H1975 cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921